159 related articles for article (PubMed ID: 17384922)
1. Targeting of human renal tumor-derived endothelial cells with peptides obtained by phage display.
Bussolati B; Grange C; Tei L; Deregibus MC; Ercolani M; Aime S; Camussi G
J Mol Med (Berl); 2007 Aug; 85(8):897-906. PubMed ID: 17384922
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154.
Deambrosis I; Lamorte S; Giaretta F; Tei L; Biancone L; Bussolati B; Camussi G
J Mol Med (Berl); 2009 Feb; 87(2):181-97. PubMed ID: 18985310
[TBL] [Abstract][Full Text] [Related]
3. Altered angiogenesis and survival in human tumor-derived endothelial cells.
Bussolati B; Deambrosis I; Russo S; Deregibus MC; Camussi G
FASEB J; 2003 Jun; 17(9):1159-61. PubMed ID: 12709414
[TBL] [Abstract][Full Text] [Related]
4. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
[TBL] [Abstract][Full Text] [Related]
5. Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer.
Liang S; Lin T; Ding J; Pan Y; Dang D; Guo C; Zhi M; Zhao P; Sun L; Hong L; Shi Y; Yao L; Liu J; Wu K; Fan D
J Mol Med (Berl); 2006 Sep; 84(9):764-73. PubMed ID: 16763842
[TBL] [Abstract][Full Text] [Related]
6. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway.
Bussolati B; Assenzio B; Deregibus MC; Camussi G
J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472
[TBL] [Abstract][Full Text] [Related]
7. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
8. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase.
Doublier S; Ceretto M; Lupia E; Bravo S; Bussolati B; Camussi G
Clin Cancer Res; 2007 Oct; 13(19):5710-8. PubMed ID: 17908960
[TBL] [Abstract][Full Text] [Related]
9. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
Loi M; Marchiò S; Becherini P; Di Paolo D; Soster M; Curnis F; Brignole C; Pagnan G; Perri P; Caffa I; Longhi R; Nico B; Bussolino F; Gambini C; Ribatti D; Cilli M; Arap W; Pasqualini R; Allen TM; Corti A; Ponzoni M; Pastorino F
J Control Release; 2010 Jul; 145(1):66-73. PubMed ID: 20346382
[TBL] [Abstract][Full Text] [Related]
10. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.
Kelly KA; Allport JR; Tsourkas A; Shinde-Patil VR; Josephson L; Weissleder R
Circ Res; 2005 Feb; 96(3):327-36. PubMed ID: 15653572
[TBL] [Abstract][Full Text] [Related]
11. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
12. Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures.
Bussolati B; Grange C; Bruno S; Buttiglieri S; Deregibus MC; Tei L; Aime S; Camussi G
Exp Cell Res; 2006 Apr; 312(6):913-24. PubMed ID: 16406048
[TBL] [Abstract][Full Text] [Related]
13. A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.
Matsuo AL; Juliano MA; Figueiredo CR; Batista WL; Tanaka AS; Travassos LR
Mol Cancer Res; 2011 Nov; 9(11):1471-8. PubMed ID: 21900362
[TBL] [Abstract][Full Text] [Related]
14. Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis.
Thapa N; Hong HY; Sangeetha P; Kim IS; Yoo J; Rhee K; Oh GT; Kwon IC; Lee BH
J Control Release; 2008 Oct; 131(1):27-33. PubMed ID: 18680772
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe.
Geninatti Crich S; Bussolati B; Tei L; Grange C; Esposito G; Lanzardo S; Camussi G; Aime S
Cancer Res; 2006 Sep; 66(18):9196-201. PubMed ID: 16982763
[TBL] [Abstract][Full Text] [Related]
16. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
17. A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library.
Brown CK; Modzelewski RA; Johnson CS; Wong MK
Ann Surg Oncol; 2000 Dec; 7(10):743-9. PubMed ID: 11129422
[TBL] [Abstract][Full Text] [Related]
18. Attaching the phage display-selected GLA peptide to liposomes: factors influencing target binding.
van Rooy I; Hennink WE; Storm G; Schiffelers RM; Mastrobattista E
Eur J Pharm Sci; 2012 Feb; 45(3):330-5. PubMed ID: 22155541
[TBL] [Abstract][Full Text] [Related]
19. Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides.
Trepel M; Pasqualini R; Arap W
Methods Enzymol; 2008; 445():83-106. PubMed ID: 19022056
[TBL] [Abstract][Full Text] [Related]
20. [In-vivo screening and characterization of peptides specific for vasculature of gastric cancer].
Wang Y; Wu KC; Nie YZ; Han ZY; Han QL; Qiao TD; Fan DM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):469-72. PubMed ID: 15169660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
